{"entity":"novartis","name":"Novartis","kind":null,"summary":"Novartis' timeline holds 61 claims from 2008 to 2025: 1 people, 48 money & deals, 12 other. 11 are undated. The latest took effect on December 31, 2025.","counts":{"total":61,"by_kind":{"people":1,"money":48,"products":0,"models":0,"other":12}},"events":[{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis headquarters: Basel\", undated. Claim clm_0F722C0A09FC, https://asof.is/claim/clm_0F722C0A09FC, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_0F722C0A09FC","accessed":"2026-11-09"},"kind":"other","predicate":"headquarters","value":"Basel","status":"valid","assertable":true,"id":"clm_0F722C0A09FC","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis listed on: OTC\", undated. Claim clm_626AF6641092, https://asof.is/claim/clm_626AF6641092, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_626AF6641092","accessed":"2026-11-09"},"kind":"other","predicate":"listed_on","value":"OTC","status":"valid","assertable":true,"id":"clm_626AF6641092","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis state of incorporation: V8\", undated. Claim clm_64105409876F, https://asof.is/claim/clm_64105409876F, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_64105409876F","accessed":"2026-11-09"},"kind":"other","predicate":"state_of_incorporation","value":"V8","status":"valid","assertable":true,"id":"clm_64105409876F","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis ticker: NVSEF\", undated. Claim clm_75D99E5C33AE, https://asof.is/claim/clm_75D99E5C33AE, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_75D99E5C33AE","accessed":"2026-11-09"},"kind":"other","predicate":"ticker","value":"NVSEF","status":"valid","assertable":true,"id":"clm_75D99E5C33AE","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis registrant name: NOVARTIS AG\", undated. Claim clm_9ECB34CF2487, https://asof.is/claim/clm_9ECB34CF2487, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_9ECB34CF2487","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"NOVARTIS AG","status":"valid","assertable":true,"id":"clm_9ECB34CF2487","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis listed on: NYSE\", undated. Claim clm_A272094EA644, https://asof.is/claim/clm_A272094EA644, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_A272094EA644","accessed":"2026-11-09"},"kind":"other","predicate":"listed_on","value":"NYSE","status":"valid","assertable":true,"id":"clm_A272094EA644","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis cik: 0001114448\", undated. Claim clm_B49F45CDC592, https://asof.is/claim/clm_B49F45CDC592, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_B49F45CDC592","accessed":"2026-11-09"},"kind":"other","predicate":"cik","value":"0001114448","status":"valid","assertable":true,"id":"clm_B49F45CDC592","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis fiscal year end: 12-31\", undated. Claim clm_CF6F00F357D4, https://asof.is/claim/clm_CF6F00F357D4, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_CF6F00F357D4","accessed":"2026-11-09"},"kind":"other","predicate":"fiscal_year_end","value":"12-31","status":"valid","assertable":true,"id":"clm_CF6F00F357D4","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_F61B5ED25295, https://asof.is/claim/clm_F61B5ED25295, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_F61B5ED25295","accessed":"2026-11-09"},"kind":"other","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","status":"valid","assertable":true,"id":"clm_F61B5ED25295","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis ticker: NVS\", undated. Claim clm_FF3D83D13D18, https://asof.is/claim/clm_FF3D83D13D18, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_FF3D83D13D18","accessed":"2026-11-09"},"kind":"other","predicate":"ticker","value":"NVS","status":"valid","assertable":true,"id":"clm_FF3D83D13D18","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis website: http://www.novartis.com/\", undated. Claim clm_684F998583E7, https://asof.is/claim/clm_684F998583E7, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q507154.","url":"https://asof.is/claim/clm_684F998583E7","accessed":"2026-11-09"},"kind":"other","predicate":"website","value":"http://www.novartis.com/","status":"unverified","assertable":false,"why_not":"low_confidence","id":"clm_684F998583E7","evidence":{"by":"own-site","on":"2026-11-08","quote":"Novartis.","url":"https://www.novartis.com/"}},{"date":"2008-11-06","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis x username: Novartis\", as of 2008-11-06. Claim clm_8BF4C723A097, https://asof.is/claim/clm_8BF4C723A097, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q507154.","url":"https://asof.is/claim/clm_8BF4C723A097","accessed":"2026-11-09"},"kind":"other","predicate":"x_username","value":"Novartis","status":"unverified","assertable":false,"why_not":"unverified","id":"clm_8BF4C723A097","evidence":{"by":"own-site","on":"2026-11-08","quote":"https://x.com/novartis","url":"http://www.novartis.com/"}},{"date":"2015-12-31","until":"2016-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 77,122,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_F4A7EF9247D5, https://asof.is/claim/clm_F4A7EF9247D5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_F4A7EF9247D5","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"77,122,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4A7EF9247D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2018, filed 2019-01-30"}},{"date":"2016-12-31","until":"2017-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 74,891,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_1F7255C1F465, https://asof.is/claim/clm_1F7255C1F465, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_1F7255C1F465","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"74,891,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1F7255C1F465","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2018, filed 2019-01-30"}},{"date":"2016-12-31","until":"2017-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 6,698,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_A450BC25D4EC, https://asof.is/claim/clm_A450BC25D4EC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_A450BC25D4EC","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"6,698,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A450BC25D4EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2018, filed 2019-01-30"}},{"date":"2016-12-31","until":"2017-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 8,268,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_EE8DEE22E155, https://asof.is/claim/clm_EE8DEE22E155, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_EE8DEE22E155","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"8,268,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE8DEE22E155","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2018, filed 2019-01-30"}},{"date":"2017-12-31","until":"2018-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 8,629,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_0526738C57FA, https://asof.is/claim/clm_0526738C57FA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_0526738C57FA","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"8,629,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0526738C57FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2018, filed 2019-01-30"}},{"date":"2017-12-31","until":"2018-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 7,703,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_12A2AD908EB7, https://asof.is/claim/clm_12A2AD908EB7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_12A2AD908EB7","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"7,703,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_12A2AD908EB7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2018, filed 2019-01-30"}},{"date":"2017-12-31","until":"2018-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 74,227,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_1FFF878FB953, https://asof.is/claim/clm_1FFF878FB953, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_1FFF878FB953","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"74,227,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1FFF878FB953","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2018, filed 2019-01-30"}},{"date":"2017-12-31","until":"2018-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 133,079,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_2DC7A9C81128, https://asof.is/claim/clm_2DC7A9C81128, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_2DC7A9C81128","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"133,079,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2DC7A9C81128","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2018, filed 2019-01-30"}},{"date":"2018-01-01","until":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis ceo: Vasant (Vas) Narasimhan\", as of 2018-01-01. Claim clm_3312D1223526, https://asof.is/claim/clm_3312D1223526, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm.","url":"https://asof.is/claim/clm_3312D1223526","accessed":"2026-11-09"},"kind":"people","predicate":"ceo","value":"Vasant (Vas) Narasimhan","status":"valid","assertable":true,"id":"clm_3312D1223526","evidence":{"by":"page-read","on":"2026-11-08","quote":"Vasant (Vas) Narasimhan, M.D. Chief Executive Officer since 2018 | Nationality: American | Year of birth: 1976","url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,311,171,429 shares\", as of 2018-12-31 (until 2019-12-31). Claim clm_35A80D4D8E81, https://asof.is/claim/clm_35A80D4D8E81, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_35A80D4D8E81","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,311,171,429 shares","status":"superseded","assertable":true,"id":"clm_35A80D4D8E81","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2018, filed 2019-01-30"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 78,692,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_58FF0FED75A7, https://asof.is/claim/clm_58FF0FED75A7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_58FF0FED75A7","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"78,692,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_58FF0FED75A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2018, filed 2019-01-30"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 12,614,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_86476E83D754, https://asof.is/claim/clm_86476E83D754, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_86476E83D754","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"12,614,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_86476E83D754","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2018, filed 2019-01-30"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 145,563,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_967603AD607D, https://asof.is/claim/clm_967603AD607D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_967603AD607D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"145,563,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_967603AD607D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2018, filed 2019-01-30"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 8,169,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_D3E230AFF547, https://asof.is/claim/clm_D3E230AFF547, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_D3E230AFF547","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"8,169,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D3E230AFF547","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2018, filed 2019-01-30"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 9,086,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_0149AA2021B4, https://asof.is/claim/clm_0149AA2021B4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_0149AA2021B4","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"9,086,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0149AA2021B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2019, filed 2020-01-29"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 11,737,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_0CBFF9ABD464, https://asof.is/claim/clm_0CBFF9ABD464, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_0CBFF9ABD464","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"11,737,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0CBFF9ABD464","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2019, filed 2020-01-29"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 55,551,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_36E9C60D9850, https://asof.is/claim/clm_36E9C60D9850, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_36E9C60D9850","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"55,551,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_36E9C60D9850","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2019, filed 2020-01-29"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,265,008,488 shares\", as of 2019-12-31 (until 2020-12-31). Claim clm_657C4132B151, https://asof.is/claim/clm_657C4132B151, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_657C4132B151","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,265,008,488 shares","status":"superseded","assertable":true,"id":"clm_657C4132B151","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2019, filed 2020-01-29"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 118,370,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_6F1C27991C72, https://asof.is/claim/clm_6F1C27991C72, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_6F1C27991C72","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"118,370,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F1C27991C72","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2019, filed 2020-01-29"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 56,666,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_0BA338FA586A, https://asof.is/claim/clm_0BA338FA586A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_0BA338FA586A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"56,666,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0BA338FA586A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2020, filed 2021-01-26"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 132,059,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_4B781197482C, https://asof.is/claim/clm_4B781197482C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_4B781197482C","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"132,059,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B781197482C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2020, filed 2021-01-26"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 10,152,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_ADC8AC894691, https://asof.is/claim/clm_ADC8AC894691, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_ADC8AC894691","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"10,152,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ADC8AC894691","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2020, filed 2021-01-26"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 8,071,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_BEA4CCA5A4E8, https://asof.is/claim/clm_BEA4CCA5A4E8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_BEA4CCA5A4E8","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"8,071,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BEA4CCA5A4E8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2020, filed 2021-01-26"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,256,822,048 shares\", as of 2020-12-31 (until 2021-12-31). Claim clm_FA5B2A8636EB, https://asof.is/claim/clm_FA5B2A8636EB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_FA5B2A8636EB","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,256,822,048 shares","status":"superseded","assertable":true,"id":"clm_FA5B2A8636EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2020, filed 2021-01-26"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 24,018,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_1A520E1875F6, https://asof.is/claim/clm_1A520E1875F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_1A520E1875F6","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"24,018,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A520E1875F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2021, filed 2022-02-02"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 67,822,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_70FD421198A4, https://asof.is/claim/clm_70FD421198A4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_70FD421198A4","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"67,822,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_70FD421198A4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2021, filed 2022-02-02"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 131,795,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_91947C0A764E, https://asof.is/claim/clm_91947C0A764E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_91947C0A764E","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"131,795,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_91947C0A764E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2021, filed 2022-02-02"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,234,939,948 shares\", as of 2021-12-31 (until 2022-12-31). Claim clm_ADE03C9FEB28, https://asof.is/claim/clm_ADE03C9FEB28, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_ADE03C9FEB28","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,234,939,948 shares","status":"superseded","assertable":true,"id":"clm_ADE03C9FEB28","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2021, filed 2022-02-02"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 11,689,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_E1378382005A, https://asof.is/claim/clm_E1378382005A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_E1378382005A","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"11,689,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1378382005A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2021, filed 2022-02-02"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,119,609,057 shares\", as of 2022-12-31 (until 2023-12-31). Claim clm_009FE98CC602, https://asof.is/claim/clm_009FE98CC602, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_009FE98CC602","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,119,609,057 shares","status":"superseded","assertable":true,"id":"clm_009FE98CC602","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2022, filed 2023-02-01"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 59,423,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_35A920D02D20, https://asof.is/claim/clm_35A920D02D20, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_35A920D02D20","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"59,423,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_35A920D02D20","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2022, filed 2023-02-01"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 6,955,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_5646B015C0F8, https://asof.is/claim/clm_5646B015C0F8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_5646B015C0F8","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"6,955,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5646B015C0F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2022, filed 2023-02-01"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 9,197,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_9BE780A31D35, https://asof.is/claim/clm_9BE780A31D35, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_9BE780A31D35","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"9,197,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9BE780A31D35","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2022, filed 2023-02-01"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 117,453,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_BB5AD0135865, https://asof.is/claim/clm_BB5AD0135865, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_BB5AD0135865","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"117,453,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BB5AD0135865","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2022, filed 2023-02-01"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,044,033,986 shares\", as of 2023-12-31 (until 2024-12-31). Claim clm_0BB5090F9540, https://asof.is/claim/clm_0BB5090F9540, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_0BB5090F9540","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,044,033,986 shares","status":"superseded","assertable":true,"id":"clm_0BB5090F9540","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2023, filed 2024-01-31"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 46,750,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_19784DB0CE70, https://asof.is/claim/clm_19784DB0CE70, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_19784DB0CE70","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"46,750,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_19784DB0CE70","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2023, filed 2024-01-31"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 14,854,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_9235B12B85D4, https://asof.is/claim/clm_9235B12B85D4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_9235B12B85D4","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"14,854,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9235B12B85D4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2023, filed 2024-01-31"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 9,769,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_C54C261844E4, https://asof.is/claim/clm_C54C261844E4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_C54C261844E4","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"9,769,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C54C261844E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2023, filed 2024-01-31"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 99,945,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_E47EB2D219FD, https://asof.is/claim/clm_E47EB2D219FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_E47EB2D219FD","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"99,945,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E47EB2D219FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2023, filed 2024-01-31"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 14,544,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_2DD252AFDAA3, https://asof.is/claim/clm_2DD252AFDAA3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_2DD252AFDAA3","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"14,544,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2DD252AFDAA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2024, filed 2025-01-31"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 1,975,089,248 shares\", as of 2024-12-31 (until 2025-12-31). Claim clm_5B7C7456996A, https://asof.is/claim/clm_5B7C7456996A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_5B7C7456996A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,975,089,248 shares","status":"superseded","assertable":true,"id":"clm_5B7C7456996A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2024, filed 2025-01-31"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 11,939,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_5BF3DA7B810B, https://asof.is/claim/clm_5BF3DA7B810B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_5BF3DA7B810B","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"11,939,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5BF3DA7B810B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2024, filed 2025-01-31"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 102,246,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_BCE8770D5AC4, https://asof.is/claim/clm_BCE8770D5AC4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_BCE8770D5AC4","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"102,246,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BCE8770D5AC4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2024, filed 2025-01-31"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 44,126,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_DD45194F44A3, https://asof.is/claim/clm_DD45194F44A3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_DD45194F44A3","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"44,126,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD45194F44A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2024, filed 2025-01-31"}},{"date":"2025-12-31","until":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 110,949,000,000 United States dollar\", as of 2025-12-31. Claim clm_0705199BCCFC, https://asof.is/claim/clm_0705199BCCFC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_0705199BCCFC","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"110,949,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_0705199BCCFC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2025, filed 2026-02-04"}},{"date":"2025-12-31","until":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 17,644,000,000 United States dollar\", as of 2025-12-31. Claim clm_13AEEBEB19A6, https://asof.is/claim/clm_13AEEBEB19A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_13AEEBEB19A6","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"17,644,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_13AEEBEB19A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2025, filed 2026-02-04"}},{"date":"2025-12-31","until":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 1,908,151,679 shares\", as of 2025-12-31. Claim clm_29E1C56666EB, https://asof.is/claim/clm_29E1C56666EB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_29E1C56666EB","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,908,151,679 shares","status":"valid","assertable":true,"id":"clm_29E1C56666EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2025, filed 2026-02-04"}},{"date":"2025-12-31","until":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 46,549,000,000 United States dollar\", as of 2025-12-31. Claim clm_6DC4BBC10979, https://asof.is/claim/clm_6DC4BBC10979, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_6DC4BBC10979","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"46,549,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_6DC4BBC10979","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2025, filed 2026-02-04"}},{"date":"2025-12-31","until":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 13,967,000,000 United States dollar\", as of 2025-12-31. Claim clm_8E9D1CC51F75, https://asof.is/claim/clm_8E9D1CC51F75, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_8E9D1CC51F75","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"13,967,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_8E9D1CC51F75","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2025, filed 2026-02-04"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"sec-filing":"parsed from the SEC filing","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)","page-read":"its source page states the value and the date"}}}